Image from Google Jackets

Psoriasis : types, triggers, and treatment strategies [E-Book]

Contributor(s): Series: Dermatology--laboratory and clinical researchPublisher: New York : Nova Biomedical, [2013]Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781626185852
  • 1626185859
Subject(s): Online resources:
Contents:
PSORIASIS ; Library of Congress Cataloging-in-Publication Data ; Contents ; Preface ; Chapter 1 Keratinocytes in Psoriasis: Key Players in the Disease Process ; Abstract ; I. Skin Homeostasis and Regulation of Function; II. Psoriasis ; 1. Epidemiology ; 2. Clinical Features ; 3. Psoriasis and the Quality of Life; 4. Psoriasis-Associated Co-Morbidities ; 5. Histologic Features ; 6. Psoriasis Phenotypes ; Classification of Psoriasis According to the Clinical Phenotype ; I. Chronic Plaque Psoriasis ; II. Inverse Psoriasis ; III. Guttate Psoriasis ; IV. Erythrodermic Psoriasis.
V. Childhood Psoriasis VI. Pustular Psoriasis ; VII. Nail disease (Psoriatic Onychodystrophy) ; VIII. Psoriatic Arthritis (PsA) ; 7. Therapeutic Armamentarium ; i. Topical Therapy ; ii. Phototherapy ; Ultraviolet B Radiation (UVB) ; Acute ; Chronic ; iii. Systemic Therapy ; Etanercept is Discussed Below as A Representative of this Class of Biologic Therapies; 8. The Mystery of the Disease Origin ; 9. Emerging Drugs; The Controversial Role of DMF; Conclusion; References ; Chapter 2 Types, Triggers and Treatment Strategies of Psoriasis ; Abstract ; Introduction ; Triggering Factors.
Infections Drugs ; Cutaneous Traumas ; Stress and Psychosomatic Factors ; Alcohol ; Smoking ; Clinical Variants ; Psoriasis Vulgaris-Chronic Plaque Psoriasis ; Guttate Psoriasis ; Small Plaque Psoriasis ; Inverse Psoriasis; Seborrhoeic Psoriasis ; Scalp Psoriasis ; Palmoplantar (Non Pustular) Psoriasis ; Nail Psoriasis ; Mucous Membranes ; Pustular Psoriasis ; Erythrodermic Psoriasis ; Treatment; General Considerations ; Topical Treatments ; Corticosteroids; Vitamin D Analogues ; Tazarotene; Salicylic Acid ; Topical Calcineurin Inhibitors ; Anthralin; Coal Tar ; Phototherapy.
UVB Phototherapy Photochemotherapy; Systemic Oral Agents ; Methotrexate; Acitretin ; Cyclosporine ; Other Systemic Drugs; Biologics ; Alefacept ; Efalizumab ; Adalimumab; Etanercept ; Infliximab ; Ustekinumab ; Conclusion ; References ; Chapter 3 A New Strategy for the Treatment of Psoriasis: Keratin 17 (K17) -- Targeting Therapy ; Abstract ; Introduction ; 1. Keratin 17; 1.1. Expression and Location of Keratin 17 ; 1.2. Functions of Keratin 17; 1.3. Keratin 17 as an Immune Regulator ; 2. Keratin 17 and Psoriasis ; 2.1. Expression of K17 in Psoriasis.
2.2. K17 and Psoriasis-Associated Cytokines 2.2.1. Regulation of K17 Expression by IFN- ; 2.2.2. Regulation of K17 Expression by IL-17 and IL-22 ; 2.2.3. Signal-Regulated Kinase Pathway of K17 Expression ; 2.3. Impact of K17 on Psoriatic Autoreactive T Cells ; 2.3.1. Classic Antigens of Psoriatic T Cells in Different Types of Psoriasis; 2.3.2. Sequences in K17 Serving As Psoriatic T Cell-Epitopes ; 2.3. K17 and Autoimmune Positive Feedback Loops in Psoriasis ; 3. K17 and Treatment of Psoriasis ; 3.1. Treatments in Psoriasis ; 3.2. K17 in the Treatments of Psoriasis.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library Link to resource Available

Includes bibliographical references and index.

Description based on print version record.

PSORIASIS ; Library of Congress Cataloging-in-Publication Data ; Contents ; Preface ; Chapter 1 Keratinocytes in Psoriasis: Key Players in the Disease Process ; Abstract ; I. Skin Homeostasis and Regulation of Function; II. Psoriasis ; 1. Epidemiology ; 2. Clinical Features ; 3. Psoriasis and the Quality of Life; 4. Psoriasis-Associated Co-Morbidities ; 5. Histologic Features ; 6. Psoriasis Phenotypes ; Classification of Psoriasis According to the Clinical Phenotype ; I. Chronic Plaque Psoriasis ; II. Inverse Psoriasis ; III. Guttate Psoriasis ; IV. Erythrodermic Psoriasis.

V. Childhood Psoriasis VI. Pustular Psoriasis ; VII. Nail disease (Psoriatic Onychodystrophy) ; VIII. Psoriatic Arthritis (PsA) ; 7. Therapeutic Armamentarium ; i. Topical Therapy ; ii. Phototherapy ; Ultraviolet B Radiation (UVB) ; Acute ; Chronic ; iii. Systemic Therapy ; Etanercept is Discussed Below as A Representative of this Class of Biologic Therapies; 8. The Mystery of the Disease Origin ; 9. Emerging Drugs; The Controversial Role of DMF; Conclusion; References ; Chapter 2 Types, Triggers and Treatment Strategies of Psoriasis ; Abstract ; Introduction ; Triggering Factors.

Infections Drugs ; Cutaneous Traumas ; Stress and Psychosomatic Factors ; Alcohol ; Smoking ; Clinical Variants ; Psoriasis Vulgaris-Chronic Plaque Psoriasis ; Guttate Psoriasis ; Small Plaque Psoriasis ; Inverse Psoriasis; Seborrhoeic Psoriasis ; Scalp Psoriasis ; Palmoplantar (Non Pustular) Psoriasis ; Nail Psoriasis ; Mucous Membranes ; Pustular Psoriasis ; Erythrodermic Psoriasis ; Treatment; General Considerations ; Topical Treatments ; Corticosteroids; Vitamin D Analogues ; Tazarotene; Salicylic Acid ; Topical Calcineurin Inhibitors ; Anthralin; Coal Tar ; Phototherapy.

UVB Phototherapy Photochemotherapy; Systemic Oral Agents ; Methotrexate; Acitretin ; Cyclosporine ; Other Systemic Drugs; Biologics ; Alefacept ; Efalizumab ; Adalimumab; Etanercept ; Infliximab ; Ustekinumab ; Conclusion ; References ; Chapter 3 A New Strategy for the Treatment of Psoriasis: Keratin 17 (K17) -- Targeting Therapy ; Abstract ; Introduction ; 1. Keratin 17; 1.1. Expression and Location of Keratin 17 ; 1.2. Functions of Keratin 17; 1.3. Keratin 17 as an Immune Regulator ; 2. Keratin 17 and Psoriasis ; 2.1. Expression of K17 in Psoriasis.

2.2. K17 and Psoriasis-Associated Cytokines 2.2.1. Regulation of K17 Expression by IFN- ; 2.2.2. Regulation of K17 Expression by IL-17 and IL-22 ; 2.2.3. Signal-Regulated Kinase Pathway of K17 Expression ; 2.3. Impact of K17 on Psoriatic Autoreactive T Cells ; 2.3.1. Classic Antigens of Psoriatic T Cells in Different Types of Psoriasis; 2.3.2. Sequences in K17 Serving As Psoriatic T Cell-Epitopes ; 2.3. K17 and Autoimmune Positive Feedback Loops in Psoriasis ; 3. K17 and Treatment of Psoriasis ; 3.1. Treatments in Psoriasis ; 3.2. K17 in the Treatments of Psoriasis.

Master record variable field(s) change: 050

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice